All NEO Content

Analysis

NeoGenomics Full Year 2025 Revenue Rises to $727 Million

NeoGenomics, Inc. (Nasdaq: NEO) shares declined 5.27% in Tuesday’s trading session following the release of its fourth quarter and full...

February 17, 20263 min read

NeoGenomics, inc (NEO) Q2 2022 earnings call

NeoGenomics, inc (NASDAQ: NEO) Q2 2022 Earnings Conference

August 1, 20221 min read

NeoGenomics, inc (NEO) Q1 2022

NeoGenomics, inc (NASDAQ: NEO) Q1 2022 Earnings Conference

May 2, 20221 min read

NeoGenomics, inc (NEO) Third Quarter 2021 Financial Results Conference Call

NeoGenomics, inc (NASDAQ: NEO) Q3 2021 Earnings Conference

October 22, 20211 min read

NeoGenomics, inc (NEO) Second Quarter 2021 Financial Results Conference Call

NeoGenomics, inc (NASDAQ: NEO) Q2 2021 Earnings Conference

July 26, 20211 min read

NeoGenomics, inc (NEO) Second Quarter 2021 Financial Results Conference Call

NeoGenomics, inc (NASDAQ: NEO) Q2 2021 Earnings Conference

July 26, 20211 min read

NeoGenomics, inc (NEO) NeoGenomics Reports 9% Revenue Growth to $116 Million in the First Quarter

NeoGenomics, inc (NASDAQ: NEO) Q1 2021 Earnings Conference

April 16, 20211 min read

NeoGenomics, inc (NEO) NeoGenomics Reports 9% Revenue Growth to $116 Million in the First Quarter

NeoGenomics, inc (NASDAQ: NEO) Q1 2021 Earnings Conference

April 16, 20211 min read

Neogenomics Inc (NASDAQ: NEO) Q1 2020 Earnings Call Transcript

Neogenomics Inc (NEO) Q1 2020 earnings call dated Apr. 28, 2020 Corporate Participants: Douglas M. VanOort — Chairman of the Board of Directors and Chief Executive Officer…

April 28, 202047 min read